AVEO Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update
AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today reported financial results for the third quarter ended September 30, 2021 and provided a business update....
AVEO Oncology Reports Second Quarter 2021 Financial Results and Provides Business Update
AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2021, and provided a business update....
AVEO Oncology Reports First Quarter 2021 Financial Results and Provides Business Update
AVEO Oncology (Nasdaq: AVEO), a commercial and clinical development stage biopharmaceutical company, today reported financial results for the first quarter ended March 31, 2021 and provided a business...